Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

VRX 133.23 -2.18 (-1.61%)
price chart
Valeant Pharmaceuticals Announces Nominations For Board Of Directors
LAVAL, Quebec, April 23, 2014 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced today its nominees to stand for election to the Board of Directors at its annual meeting of shareholders on May 20, 2014.
Related articles »  
Valeant Pharmaceuticals shares climb as it teams up with Bill Ackman to buy ...
Quebec-based Valeant Pharmaceuticals International Inc. said Monday it intends to propose a merger with California-based Allergan, using a combination of stock and cash, with the cash portion worth �around $15-billion,� according to U.S.
Valeant Proposes to Combine With Allergan for $48.30 in Cash and 0.83 Shares ...  Canada NewsWire (press release)
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Ackman Bid to Buyout ...  US Trade Media
Related articles »  
Valeant Pharmaceuticals May Be Allergan's Best Offer: Analysts
Chris Schott of JPMorgan believes a merger of the two companies would be a �compelling transaction� and a �clear strategic fit� for Allergan, Inc. (NYSE:AGN).
Valeant Pharmaceuticals Intl Inc (VRX) Updates FY14 Earnings Guidance
Valeant Pharmaceuticals Intl logo Valeant Pharmaceuticals Intl Inc (NYSE:VRX) issued an update on its FY14 earnings guidance on Tuesday morning.
Valeant Pharmaceuticals Intl Target of Unusually High Options Trading (VRX)
Valeant Pharmaceuticals International, Inc, formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products.
Valeant Pharmaceuticals Intl Coverage Initiated at Jefferies Group (VRX)  Watch List News (press release)
Valeant Pharmaceuticals International (VRX) Is Today's Pre-Market Mover ...
Related articles »  
Valeant Pharmaceuticals Intl Stock Rating Upgraded by TD Securities (BVF)
Valeant Pharmaceuticals Intl Inc logo Valeant Pharmaceuticals Intl (NYSE:BVF) was upgraded by equities researchers at TD Securities from a �hold� rating to a �buy� rating in a research report issued on Wednesday, American Banking News reports.
Why These Stocks Gained: Sunedison Inc (NYSE:SUNE), Valeant ...
The unlikely teaming up of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Allergan's single largest shareholder, will see Allergan's shareholders getting $48.30 in cash and and 0.83 percent in Valeant stock for each share they own, according to a ...
Related articles »  
Valeant Pharmaceuticals International (VRX) Soars: Stock Up 7.5%
Valeant Pharmaceuticals International, Inc. (VRX - Snapshot Report) was a big mover last session, as its shares rose nearly 8% on the day.
Related articles »  
Valeant Pharmaceuticals International Inc. Offers to Buy Botox Giant Allergan Inc.
In a cash-and-stock deal valued at $45.7 billion, Valeant Pharmaceuticals Inc. would give Allergan investors $48.30 in cash and 0.83 percent in Valeant stock for each share they own. Pershing Square Capital Management LP, the fund run by Bill Ackman, ...
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's Post ...
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide.